PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial

BACKGROUND: Infectious keratitis is a major cause of global blindness. We tested whether standalone photoactivated chromophore corneal cross-linking (PACK-CXL) may be an effective first-line treatment in early to moderate infectious keratitis, compared with standard antimicrobial treatment. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafezi, Farhad, Hosny, Mohammed, Shetty, Rohit, Knyazer, Boris, Chen, Shihao, Wang, Qinmei, Hashemi, Hassan, Torres-Netto, Emilio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742313/
https://www.ncbi.nlm.nih.gov/pubmed/34996516
http://dx.doi.org/10.1186/s40662-021-00272-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742313/
https://www.ncbi.nlm.nih.gov/pubmed/34996516
http://dx.doi.org/10.1186/s40662-021-00272-0

Ejemplares similares